Menu
Recruiting NCT06442930

EXtubation Related Complications - the EXTUBE Study (EXTUBE)

Observational Extubation

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Extubation. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States, Australia, Canada, Colombia, Ireland +3
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

EXtubation Related Complications - an International Observational Study To Understand the Impact and BEst Practices in the Operating Room and Intensive Care Unit - the EXTUBE Study

Overview

EXTUBE is an international, multicentre, prospective cohort study evaluating the incidence, risk factors, and outcomes of extubation-related complications and describing clinical practices related to extubation after general anesthesia or after critical illness in the operating room (OR), out of OR anesthesia location or intensive care unit (ICU).

Detailed description

Globally, over 200 million people each year require extubation. While routinely performed, extubation is a skilled and potentially high-risk procedure that should be performed only when physiologic, pharmacologic, and contextual conditions are optimal. Complications at this stage of patient care can result in decreased oxygen delivery to the brain and body, sometimes leading to serious adverse events such as cardiac arrest, brain damage, or death. Indeed, one quarter of airway complications that result in death or brain death occur at the time of extubation.

Despite the frequency of extubation and the potential for life-threatening complications, there is a lack of systematic data on the rate and circumstances under which these severe complications occur. The limited data indicate 10-30% of extubations may lead to severe complications, depending on the population and outcome definition. However, the certainty of these estimates is severely limited because they are based on studies that are small, mostly single-center, based on clinician recall, only capture a small portion of extubation complications (e.g., malpractice claims), or do not reflect current clinical practice. In addition, most lack a denominator and exclude successful extubations, making estimates of actual complication rates and risk factors impossible.

There has been no large study of extubation techniques or adherence to guidelines, so procedural factors associated with complications must be elucidated. While adherence to clinical practice guidelines has not been formally evaluated, surveys show non-adherence to some best practices and considerable variation in practice, and data from audits and medicolegal claims show that lack of adherence to best practices is frequently at the root cause of severe adverse extubation outcomes, with half of the complications deemed preventable. Therefore, data on the frequency and nature of extubation complications, patient and procedural risk factors for complications, and guideline adherence rates are needed before these preventable events can be addressed.

EXTUBE (EXtubation related complications - an international observational study To Understand the impact and BEst practices in the operating room and intensive care unit) is an international, multicenter, prospective cohort study

The primary objective of this study is to estimate the incidence of immediate complications related to extubation in adult patients after general anesthesia and/or after critical illness. The secondary objectives are to determine: 1) the incidence of mild extubation complications; 2) patient- and procedure-related risk factors for extubation complications; 3) the association between extubation complications and outcomes until hospital discharge; and 4) the rate of adherence to extubation clinical practice guidelines.

Primary outcome measures

  • At least one of the following, occurring within 60minutes after extubation (composite outcome): i) Severe hypoxemia ii) Cardiac arrest iii) Need for airway management [Time frame: Within 60 minutes after the end of extubation]
Secondary outcome measures (12)
  • Difficult airway and complications related to airway management if reintubation is required [Time frame: Within 60 minutes after the end of extubation]
  • Planned and unplanned non-invasive respiratory support [Time frame: Within 60 minutes after the end of extubation]
  • Emergency front of neck airway [Time frame: Within 60 minutes after the end of extubation]
  • Cardiac arrhythmia requiring chemical or electrical treatment [Time frame: Within 60 minutes after the end of extubation]
  • Severe Hypotension [Time frame: Within 60 minutes after the end of extubation]
  • Severe Hypertension [Time frame: Within 60 minutes after the end of extubation]
  • Pulmonary aspiration [Time frame: Within 60 minutes after the end of extubation]
  • Barotrauma [Time frame: Within 60 minutes after the end of extubation]
  • Dental injury [Time frame: Within 60 minutes after the end of extubation]
  • Airways injury [Time frame: Within 60 minutes after the end of extubation]
  • Mortality [Time frame: Within 7 days after extubation]
  • Re-intubation [Time frame: Within 48 hours after extubation]

Eligibility criteria

Inclusion criteria

  • Adult patients (≥18 years old)
  • Undergoing extubation of an endotracheal tube (including index extubation and re-extubations) after general anesthesia in the OR, out of OR anesthesia location or ICU
  • Undergoing extubation during the specified enrollment window

Exclusion criteria

  • Patients will be excluded if the extubation is performed in the context of withdrawal of life support measures,
  • Patients will be excluded if the extubation is performed for tracheostomy decannulation

For each patient who is not included, reasons for exclusion will be reported.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

Canada · 9 centers
  • Surrey Memorial Hospital — Surrey
  • The Moncton Hospital — Moncton
  • Sunnybrook Hospital — North York
  • Niagara Health - Marotta Family Hospital — Saint Catharines
  • St. Michael's Hospital — Toronto
  • Mount Sinai Hospital — Toronto
  • University Health Network - Toronto General Hospital — Toronto
  • University Health Network - Toronto Western Hospital — Toronto
  • … and 1 more center
United States · 6 centers
  • Banner University Medical Centre — Tucson
  • University of Arkansas for Medical Sciences — Little Rock
  • University of Florida — Gainesville
  • The University of Chicago — Chicago
  • Oregon Health & Science University — Portland
  • The University of Texas Health Science Center — Houston
Australia · 6 centers
  • Royal North Shore Hospital — Sydney
  • The Northern Hospital — Melbourne
  • Austin Hospital — Melbourne
  • Eastern Health - Box Hill Hospital — Melbourne
  • Eastern Health - Maroondah Hospital — Melbourne
  • Eastern Health - Angliss Hospital — Melbourne
Ireland · 5 centers
  • Mayo University Hospital — Castlebar
  • Cork University Hospital — Cork
  • Mater Misericordiae University Hospital — Dublin
  • Galway University Hospitals — Galway
  • University Hospital Waterford — Waterford
New Zealand · 2 centers
  • Southland Hospital — Invercargill
  • Rotorua Hospital — Rotorua
United Kingdom · 2 centers
  • Royal United Hospitals Bath — Bath
  • Freeman Hospital — Newcastle upon Tyne
Colombia · 1 center
  • Hospital Internacional de Colombia — Piedecuesta
Singapore · 1 center
  • Tan Tock Seng Hospital — Singapore

Identifiers

NCT: NCT06442930 · 24-5811 · 4850

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗